Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Sleep Disorders, Circadian Rhythm × Melatonin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 5 Sleep Wake Disorders 1 Sleep Disorders, Circadian Rhythm 1 Radiodermatitis 1 Radiation Injuries 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Pain 1 Neoplasms 1 Neoplasm Metastasis 1 Keratosis, Actinic 1 Hematologic Neoplasms 1 Head and Neck Neoplasms 1 Depression 1 Delirium 1 Brain Neoplasms 1 Brain Concussion 1

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03205033 2017-07-02

Melatonin as a Circadian Clock Regulator, Neuromodulator and Myelo-protector in Adjuvant Breast Cancer Chemotherapy

Hospital de Clinicas de Porto Alegre

Phase 2 Completed

Breast Neoplasms, Depression, Pain, Sleep Disorders, Circadian Rhythm

Data powered by HemOnc (CC BY 4.0) Colophon ⚡